Genscript Biotech (GNNSF) Short Interest Ratio & Short Volume C$1.67 -0.28 (-14.36%) As of 07/11/2025 12:50 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Genscript Biotech Short Interest DataGenscript Biotech (GNNSF) has a short interest of 7.50 million shares. This marks a 1.68% increase in short interest from the previous month. The short interest ratio (days to cover) is 75,032.0, indicating that it would take 75,032.0 days of the average trading volume of 3,358 shares to cover all short positions.Current Short Interest7,503,200 sharesPrevious Short Interest7,379,200 sharesChange Vs. Previous Month+1.68%Dollar Volume Sold Short$16.51 millionShort Interest Ratio75,032.0 Days to CoverLast Record DateJune 30, 2025Today's Trading Volume200 sharesAverage Trading Volume3,358 sharesToday's Volume Vs. Average6% Short Selling Genscript Biotech? Sign up to receive the latest short interest report for Genscript Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNNSF Short Interest Over TimeGNNSF Days to Cover Over TimeGNNSF Percentage of Float Shorted Over Time Genscript Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20257,503,200 shares C$16.51 million +1.7%N/A75032 $2.20 6/15/20257,379,200 shares C$16.23 million +0.2%N/A6149.3 $2.20 5/31/20257,366,400 shares C$9.98 million +0.2%N/A0 $1.36 5/15/20257,349,000 shares C$9.96 million -1.4%N/A36745 $1.36 4/30/20257,450,600 shares C$9.69 million -1.4%N/A0 $1.30 4/15/20257,558,600 shares C$9.83 million +131.4%N/A2042.9 $1.30 3/31/20253,266,600 shares C$4.90 million +832.3%N/A10888.7 $1.50 3/15/2025350,400 shares C$504.58 thousand -10.3%N/A438 $1.44 2/28/2025390,400 shares C$741.76 thousand -29.0%N/A300.3 $1.90 2/15/2025549,600 shares C$681.50 thousand -70.6%N/A2748 $1.24The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $7 1/31/20251,867,800 shares C$2.53 million -40.1%N/A217.2 $1.36 1/15/20253,117,800 shares C$3.96 million -36.9%N/A44.7 $1.27 12/31/20244,938,600 shares C$6.27 million +3.5%N/A7055.1 $1.27 12/15/20244,770,600 shares C$5.96 million -0.7%N/A1325.2 $1.25 11/30/20244,802,600 shares C$6.58 million -13.7%N/A1778.7 $1.37 11/15/20245,562,800 shares C$7.73 million +2.5%N/A13907 $1.39 10/31/20245,426,400 shares C$8.33 million -3.5%N/A2359.3 $1.54 10/15/20245,624,400 shares C$7.87 million -11.9%N/A14061 $1.40 9/30/20246,386,400 shares C$8.94 million -6.0%N/A3548 $1.40 9/15/20246,791,800 shares C$9.58 million +1.2%N/A16979.5 $1.41 8/31/20246,713,800 shares C$10.22 million -1.5%N/A16784.5 $1.52 8/15/20246,817,800 shares C$10.94 million +4.6%N/A114 $1.61 7/31/20246,519,800 shares C$10.46 million +16.7%N/A65198 $1.61 7/15/20245,588,000 shares C$8.94 million +6.4%N/A46.5 $1.60 6/30/20245,253,800 shares C$5.52 million +1.9%N/A0 $1.05 6/15/20245,158,200 shares C$5.42 million -21.3%N/A1394.1 $1.05 5/31/20246,557,600 shares C$9.18 million -5.7%N/A42.4 $1.40 5/15/20246,955,800 shares C$10.23 million -34.8%N/A69.3 $1.47 4/30/202410,662,000 shares C$16.10 million +118.8%N/A1239.8 $1.51 4/15/20244,873,900 shares C$9.75 million +288.1%N/A955.7 $2.00 3/31/20241,255,900 shares C$2.51 million -17.9%N/A138 $2.00 3/15/20241,530,000 shares C$3.14 million -26.3%N/A2550 $2.05 2/29/20242,076,000 shares C$4.14 million -31.1%N/A1596.9 $1.99 2/15/20243,014,000 shares C$5.27 million -16.2%N/A418.6 $1.75 1/15/20243,594,000 shares C$8.77 million -7.6%N/A73.3 $2.44 12/31/20233,888,000 shares C$9.49 million -5.8%N/A9994.9 $2.44 12/15/20234,125,000 shares C$13.20 million -6.6%N/A165.7 $3.20 11/30/20234,414,100 shares C$14.12 million +0.9%N/A44141 $3.20 11/15/20234,376,100 shares C$12.45 million -7.4%N/A71.7 $2.85 10/31/20234,726,000 shares C$12.46 million -4.4%N/A381.1 $2.64The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $7 10/15/20234,942,000 shares C$13.03 million +7.5%N/A0 $2.64 9/30/20234,596,000 shares C$12.12 million +2.6%N/A15320 $2.64 9/15/20234,478,000 shares C$10.84 million -5.7%N/A99.1 $2.42 8/31/20234,748,000 shares C$10.26 million -13.9%N/A43963 $2.16 8/15/20235,515,500 shares C$11.91 million -27.6%N/A79.4 $2.16 7/31/20237,621,500 shares C$16.46 million +2.9%N/A82.2 $2.16 7/15/20237,405,600 shares C$15.92 million -5.3%N/A74056 $2.15 6/30/20237,816,500 shares C$17.63 million +1.1%N/A186.1 $2.26 6/15/20237,734,500 shares C$18.18 million +6.2%N/A332 $2.35 5/31/20237,286,500 shares C$18.94 million +7.7%N/A36432.5 $2.60 5/15/20236,764,500 shares C$17.32 million +22.5%N/A67645 $2.56 4/30/20235,524,500 shares C$14.14 million +31.8%N/A1905 $2.56 4/15/20234,192,500 shares C$10.44 million +73.7%N/A41925 $2.49 3/31/20232,413,500 shares C$5.62 million +64.5%N/A8045 $2.33 3/15/20231,467,000 shares C$3.68 million +20.9%N/A3667.5 $2.51 2/28/20231,213,000 shares C$3.44 million +16.3%N/A3032.5 $2.84 2/15/20231,043,000 shares C$3.02 million +109.9%N/A2607.5 $2.90 1/31/2023497,000 shares C$1.69 million +16.9%N/A828.3 $3.41 1/15/2023425,000 shares C$1.46 million -8.2%N/A386.4 $3.44 12/30/2022463,000 shares C$1.37 million -3.3%N/A2315 $2.96 12/15/2022479,000 shares C$1.44 million -5.6%N/A2395 $3.00 11/30/2022507,200 shares C$1.21 million -10.4%N/A11.9 $2.38 11/15/2022566,000 shares C$1.63 million -20.6%N/A2830 $2.88 10/31/2022713,000 shares C$1.80 million +0.3%N/A68.6 $2.53 10/15/2022711,200 shares C$1.34 million +0.5%N/A52.3 $1.89 9/30/2022708,000 shares C$1.64 million +43.2%N/A643.6 $2.32 9/15/2022494,300 shares C$1.27 million +2.1%N/A329.5 $2.57 8/31/2022484,000 shares C$1.69 million +14.7%N/A4840 $3.49 8/15/2022422,000 shares C$1.58 million -26.0%N/A844 $3.75 7/31/2022570,000 shares C$2.22 million -8.4%N/A0 $3.90 7/15/2022622,000 shares C$2.43 million -21.7%N/A100.3 $3.90 6/30/2022794,300 shares C$2.79 million +16.5%N/A1323.8 $3.51 6/15/2022682,000 shares C$2.36 million -17.6%N/A2273.3 $3.47 5/31/2022828,000 shares C$2.17 million +42.8%N/A360 $2.62 5/15/2022580,000 shares C$1.38 million +80.1%N/A161.1 $2.38 4/30/2022322,000 shares C$904.82 thousand 0.0%N/A536.7 $2.81 4/15/2022322,100 shares C$985.30 thousand -11.5%N/A51.1 $3.06 3/31/2022364,100 shares C$1.27 million -60.5%N/A82.8 $3.49 3/15/2022922,500 shares C$2.32 million +2.4%N/A80.2 $2.52 2/28/2022900,500 shares C$3.43 million -34.0%N/A450.3 $3.81 2/15/20221,364,100 shares C$4.80 million -6.6%N/A593.1 $3.52 1/31/20221,460,500 shares C$4.49 million +73.6%N/A1622.8 $3.08 1/15/2022841,400 shares C$3.57 million +118.9%N/A1682.8 $4.24 12/31/2021384,300 shares C$0.00 -22.5%N/A3843 $0.00 GNNSF Short Interest - Frequently Asked Questions What is Genscript Biotech's current short interest? Short interest is the volume of Genscript Biotech shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 7,503,200 shares of GNNSF short. Learn More on Genscript Biotech's current short interest. What is a good short interest ratio for Genscript Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNNSF shares currently have a short interest ratio of 75,032.0. Learn More on Genscript Biotech's short interest ratio. Is Genscript Biotech's short interest increasing or decreasing? Genscript Biotech saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 7,503,200 shares, an increase of 1.7% from the previous total of 7,379,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Genscript Biotech stock? Short selling GNNSF is an investing strategy that aims to generate trading profit from Genscript Biotech as its price is falling. GNNSF shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genscript Biotech? A short squeeze for Genscript Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNNSF, which in turn drives the price of the stock up even further. How often is Genscript Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNNSF, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest AGNPF Short Interest AKBLF Short Interest APLMW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest AXIM Short Interest BCTXW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNNSF) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genscript Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genscript Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
